ANNUAL MEDICAL DEVICE CORPORATE STRATEGY AND BUSINESS DEVELOPMENT CONFERENCE, DALLAS, JANUARY 29-30, 2019
Within the continuously evolving medical device industry, corporate strategy and business development executives face a range of challenges as they pursue opportunities for expansion. While mergers and acquisitions remain undeniably profitable, industry leaders now recognize a need for innovative partnerships, licensing arrangements, and distribution agreements in order to further sustain growth. As each opportunity and potential deal structure presents unique attributes, working toward optimization and standardization of internal processes is key to maximizing evaluation effectiveness and ensuring a sound business decision is made. In addition, with evolving requirements such as corporate tax overhaul and international trade tariffs, as well as rapidly changing healthcare reimbursement policies, new and challenging factors are necessary to consider as companies calculate valuation of potential partnerships and acquisitions.
The 5th edition of the Q1 Medical Device Corporate Strategy & Business Development Conference will explore various topics of timely importance to industry executives, including the building of valuation models in a market that is currently experiencing all-time highs. Subjective factors that influence long-term deal success, such as alignment of company culture, will also be examined. Through a variety of perspectives including industry, legal, and venture capital investment, issues of critical importance to executives will be addressed in an engaging and participatory manner. To further enhance understanding of unique solutions to complex challenges, participants will also have the opportunity to engage in small group formats and share insight among peers, fostering a must-attend educational and networking event.